Nextrials, Inc. Revenues Jump 60 Percent

SAN RAMON, Calif.--(BUSINESS WIRE)--Nextrials, Inc., a leader in clinical research software and services, experienced more than 60 percent revenue growth and a double digit increase in sales during the first half of 2007 over the same time period in 2006, demonstrating the pharmaceutical, biotechnology and medical device industries’ accelerating interest in the elimination of paper-based data collection in clinical trials. Nextrials’ flagship product, Prism®, has now gained global support from clinical trial managers and sponsors for its award-winning features and easy-to-use interfaces; customers are also showing strong interest in the new PRT module being developed for automatic patient recruitment identification and randomization.
MORE ON THIS TOPIC